Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy

Sponsor

Kafrelsheikh University (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05788367

Collaborator

(none)

Enrollment

Location

Arms

Study Details

Study Description

Brief Summary

The aim of this study is to compare PENG and ISB after shoulder arthroscopy for postoperative pain management after shoulder arthroscopy.

Condition or Disease	Intervention/Treatment	Phase
Pericapsular Nerve Block Interscalene Nerve Block Shoulder Arthroscopy	Procedure: The pericapsular nerve group Procedure: Interscalene brachial plexus block	N/A

Detailed Description

Shoulder arthroscopy is a common procedure done is orthopedics for many surgical indications as rotator cuff tears, stiffness and instability. This procedure has a well - documented postoperative pain. To improve the outcome after surgery, effective pain control is needed.

Various methods are used for postoperative pain management. Intravenous opioid agents are among them, but they may cause undesirable side effects, such as respiratory depression, sedation, constipation, allergic reaction, nausea, and vomiting. Thus, alternative techniques are preferred.

Interscalene brachial plexus blocks (ISBPBs) are often used to provide perioperative analgesia and anesthesia for shoulder surgery. They target nerve roots C4-C6 and thereby provide regional analgesia to the shoulder and upper arm. Although ISBPBs are often performed in combination with general anesthesia (GA) to enhance postoperative analgesia, they are also sometimes used as a sole means of anesthesia.

The pericapsular nerve group (PENG) block is an ultrasound-guided approach, first described by Giron-Arango et al. for the blockade of the articular branches of the femoral, obturator and accessory obturator nerves that provide sensory innervation to the anterior hip capsule. It has been successfully used as an alternative regional anaesthesia technique for the management of acute pain after hip fracture, and for analgesia after elective hip surgery

Study Design

Study Type:

Interventional

Anticipated Enrollment :

44 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Triple (Participant, Care Provider, Investigator)

Primary Purpose:

Treatment

Official Title:

Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy: A Randomized Controlled Study

Anticipated Study Start Date :

Jul 15, 2023

Anticipated Primary Completion Date :

Jul 15, 2023

Anticipated Study Completion Date :

Jul 15, 2023

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: The pericapsular nerve group patients received Ultrasound guided The pericapsular nerve group block using 20 ml of bupivacaine 0.5%	Procedure: The pericapsular nerve group patients received Ultrasound guided pericapsular nerve group block using 20 ml of bupivacaine 0.5%
Active Comparator: Interscalene group patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia.	Procedure: Interscalene brachial plexus block patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia

Arm

Intervention/Treatment

Active Comparator: The pericapsular nerve group

patients received Ultrasound guided The pericapsular nerve group block using 20 ml of bupivacaine 0.5%

Procedure: The pericapsular nerve group

patients received Ultrasound guided pericapsular nerve group block using 20 ml of bupivacaine 0.5%

Active Comparator: Interscalene group

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia.

Procedure: Interscalene brachial plexus block

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia

Outcome Measures

Primary Outcome Measures

Asses The postoperative opioid consumption [24 hours postoperatively]
the postoperative opioid consumption during the procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 65 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Body mass index < 40 kg/m2
American Society of Anesthesiologists (ASA) physical status I-II
posted for elective shoulder arthroscopy

Exclusion Criteria:

Known allergy to local anesthetics
allergy to all opioid medications
diagnostic shoulder arthroscopic procedures
patients with chronic opioids use and coagulopathy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Mohammed Fouad Mohamed Algyar	Kafrelsheikh		Egypt	33516

Sponsors and Collaborators

Kafrelsheikh University

Investigators

Principal Investigator: Mohammed F Algyar, MD, Lecturer of Anaesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Mohamed Fouad Algyar, Lecturer of Anaesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh University

ClinicalTrials.gov Identifier:

NCT05788367

Other Study ID Numbers:

MKSU 50-12-7

First Posted:

Mar 28, 2023

Last Update Posted:

Mar 28, 2023

Last Verified:

Mar 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Acute Pain

Study Results

No Results Posted as of Mar 28, 2023